healthcare providers to prescribe GSK drugs in return in violation of the federal Anti-Kickback law and the analogous anti-kickback laws of the Plaintiff States.Top level GSK managers and executives, including but not limited to GSK's Chief Executive Officer J.P. Garnier, current President of Pharmaceutical Operations David Stout, Vice Chairman of Pharmaceuticals (and former President of Pharmaceu